SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Reported institutional adoption is driving attention, with traders highlighting NYSE/ICE testing Avalanche for tokenized securities, Charles Schwab access, and broader real-world-asset activity. The community is split between bullish momentum and skepticism that the move is another pump-and-dump, citing weak follow-through and recurring selloffs.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat is drawing attention after traders reacted to its failure to place among the leading companies in the Armys Gauntlet II drone competition, intensifying concerns about lost defense-contract opportunities and managements repeated promises. Some holders argue the contest targeted lower-margin FPV drones and that Black Widow, reconnaissance products, and Blue Ops remain viable, while bearish commentary focuses on weak sales, delayed contracts, insider selling, and executive credibility.

Cash Cat

A sharp selloff following CASHCATs speculative meme-coin rally and record highs is driving attention, with traders debating whether the decline is a buying opportunity or evidence of a pump-and-dump. Bulls cite its Robinhood Chain ties, claimed buyback-and-burn activity and potential exchange exposure, while bears point to repeated failed breakouts, weak support and continued downside.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Delayed clinical milestones and investor presentations offering little new information have fueled attention around Corvus, with traders especially debating the postponed PTCL analysis, limited updates on ALPS, and the timing of Soquelitinib data. Bearish participants cite management credibility and execution concerns, while bulls point to the drugs early atopic-dermatitis signals, potential partnerships, and high short interest.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

A weaker Q2 sales performance and reduced full-year growth outlook have driven sustained selling in ONON, with traders focused on slowing wholesale and U.S. demand amid broader athletic-apparel weakness. Bulls argue the reaction is excessive given strong direct-to-consumer momentum, margins, cash, and product innovation, while bears see the guidance cut as evidence that the premium growth story is losing momentum.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Rotation into defensive, dividend-paying value stocks amid weakness in technology and high-beta shares has made SCHD a prominent safe-haven and income discussion. Traders are split between continuing to DCA for long-term dividend growth and arguing that its strong run has left the ETF overextended and vulnerable to profit-taking or higher bond yields.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Regulatory and compliance concerns around Hims & Hers GLP-1 offeringsincluding FDA scrutiny, the FTC case and reported Visa chargeback issuesare driving the debate. Bullish traders argue that peptide opportunities, Australia expansion and high short interest could offset those risks, while bearish participants focus on potential business disruption and continued selling pressure.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

A second fiscal 2026 guidance cut tied to persistent Houston contract-manufacturing ramp delays, supply-chain issues and delivery penalties has intensified concerns about Fluences execution and credibility, prompting a wave of analyst downgrades. Traders remain divided between bears expecting further weakness and dip-buyers who argue demand and backlog remain strong and that the new COO can help repair operations.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Strong Mounjaro and Zepbound demand, an earnings beat with raised guidance, and bullish analyst revisions are driving attention, reinforcing Lillys perceived leadership in the GLP-1 market and the growth prospects of its Foundayo pill. Traders remain divided over the premium valuation, competition from Novo Nordisks oral Wegovy, and profit-taking despite the companys broader pipeline and acquisition activity.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Speculation around a long-awaited hyperscaler lease for Galaxys Helios AI data center is the main catalyst, with traders debating whether management will deliver after repeated delays. Sentiment is split between optimism that a tenant announcement and crypto strength could support the stock, and frustration over limited communication and ERCOT classifications that left several projects in a conditional studied-load category.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Apimeds Pharmaceuticals says I love my Ducks with new ai Futures Lab Program collaboration with the University of Oregons Lundquist College of Business

Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) (Apimeds) today announced the expansion of the Apimeds ai Futures Lab program through a new collaboration with the University of Oregons Lundquist...

Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS). The company was founded on May 11, 2020 and is headquartered in Matawan, NJ.

Apimeds Pharmaceuticals US Inc.

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$1.77
Prev Close	$1.67
Open	$1.68
Dividend Yield	0.00%
50-Day Moving Average	$4.54
Beta	1.20
Avg. Volume	153,046.81
PE Ratio	-0.05

52-Week High	$59.70
52-Week Low	$1.51
Market Capitalization	$2.67M
EPS (Annual)	-$4.77
Price to Book	0.03
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

APUS Fundamentals